Gennaro Chiappetta
Gennaro Chiappetta
Istituto tumori napoli
Verified email at istitutotumori.na.it
Title
Cited by
Cited by
Year
Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27 Kip1 by PKB/Akt-mediated phosphorylation in breast cancer
G Viglietto, ML Motti, P Bruni, RM Melillo, A D'alessio, D Califano, F Vinci, ...
Nature medicine 8 (10), 1136-1144, 2002
8112002
MicroRNA deregulation in human thyroid papillary carcinomas
P Pallante, R Visone, M Ferracin, A Ferraro, MT Berlingieri, G Troncone, ...
Endocrine-related cancer 13 (2), 497-508, 2006
5782006
An increased high-mobility group A2 expression level is associated with malignant phenotype in pancreatic exocrine tissue
N Abe, T Watanabe, Y Suzuki, N Matsumoto, T Masaki, T Mori, ...
British journal of cancer 89 (11), 2104-2109, 2003
3822003
RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes.
G Tallini, M Santoro, M Helie, F Carlomagno, G Salvatore, G Chiappetta, ...
Clinical Cancer Research 4 (2), 287-294, 1998
3661998
High level expression of the HMGI (Y) gene during embryonic development
G Chiappetta, V Avantaggiato, R Visconti, M Fedele, S Battista, ...
Oncogene 13 (11), 2439-2446, 1996
3291996
RET/PTC oncogene activation is an early event in thyroid carcinogenesis.
G Viglietto, G Chiappetta, FJ Martinez-Tello, FH Fukunaga, G Tallini, ...
Oncogene 11 (6), 1207-1210, 1995
3261995
Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study
A Bartolazzi, F Orlandi, E Saggiorato, M Volante, F Arecco, R Rossetto, ...
The lancet oncology 9 (6), 543-549, 2008
3002008
High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid …
GA Thomas, H Bunnell, HA Cook, ED Williams, A Nerovnya, ...
The Journal of Clinical Endocrinology & Metabolism 84 (11), 4232-4238, 1999
2831999
Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice.
M Santoro, G Chiappetta, A Cerrato, D Salvatore, L Zhang, G Manzo, ...
Oncogene 12 (8), 1821-1826, 1996
2791996
Upregulation of vascular endothelial growth factor (VEGF) and downregulation of placenta growth factor (PlGF) associated with malignancy in human thyroid tumors and cell lines.
G Viglietto, D Maglione, M Rambaldi, J Cerutti, A Romano, F Trapasso, ...
Oncogene 11 (8), 1569-1579, 1995
2691995
RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto’s thyroiditis share low-level recombination events with a subset of …
KJ Rhoden, K Unger, G Salvatore, Y Yilmaz, V Vovk, G Chiappetta, ...
The Journal of Clinical Endocrinology & Metabolism 91 (6), 2414-2423, 2006
2152006
The expression of the high mobility group HMGI (Y) proteins correlates with the malignant phenotype of human thyroid neoplasias.
G Chiappetta, A Bandiera, MT Berlingieri, R Visconti, G Manfioletti, ...
Oncogene 10 (7), 1307-1314, 1995
2151995
The neutrophil gelatinase-associated lipocalin (NGAL), a NF-κB-regulated gene, is a survival factor for thyroid neoplastic cells
A Iannetti, F Pacifico, R Acquaviva, A Lavorgna, E Crescenzi, C Vascotto, ...
Proceedings of the National Academy of Sciences 105 (37), 14058-14063, 2008
1982008
Activating E17K mutation in the gene encoding the protein kinase AKT in a subset of squamous cell carcinoma of the lung
D Malanga, M Scrima, C De Marco, F Fabiani, N De Rosa, S De Gisi, ...
Cell cycle 7 (5), 665-669, 2008
1912008
PTEN expression is reduced in a subset of sporadic thyroid carcinomas: evidence that PTEN-growth suppressing activity in thyroid cancer cells is mediated by p27 kip1
P Bruni, A Boccia, G Baldassarre, F Trapasso, M Santoro, G Chiappetta, ...
Oncogene 19 (28), 3146-3155, 2000
1812000
Detection of high mobility group I HMGI (Y) protein in the diagnosis of thyroid tumors: HMGI (Y) expression represents a potential diagnostic indicator of carcinoma
G Chiappetta, G Tallini, MC De Biasio, G Manfioletti, FJ Martinez-Tello, ...
Cancer Research 58 (18), 4193-4198, 1998
1801998
Human colorectal carcinomas express high levels of high mobility group HMGI (Y) proteins
M Fedele, A Bandiera, G Chiappetta, S Battista, G Viglietto, G Manfioletti, ...
Cancer research 56 (8), 1896-1901, 1996
1701996
A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis
A Vecchione, B Belletti, F Lovat, S Volinia, G Chiappetta, S Giglio, ...
Proceedings of the National Academy of Sciences 110 (24), 9845-9850, 2013
1692013
Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma: a search for the early precursors of …
A Fusco, G Chiappetta, P Hui, G Garcia-Rostan, L Golden, BK Kinder, ...
The American journal of pathology 160 (6), 2157-2167, 2002
1672002
Adenovirus-mediated suppression of HMGI (Y) protein synthesis as potential therapy of human malignant neoplasias
S Scala, G Portella, M Fedele, G Chiappetta, A Fusco
Proceedings of the National Academy of Sciences 97 (8), 4256-4261, 2000
1652000
The system can't perform the operation now. Try again later.
Articles 1–20